BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 114 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $53,000 | -32.1% | 998 | -22.0% | 0.00% | – |
Q2 2020 | $78,000 | +9.9% | 1,279 | -1.5% | 0.00% | – |
Q1 2020 | $71,000 | -22.0% | 1,298 | -18.4% | 0.00% | – |
Q4 2019 | $91,000 | +26.4% | 1,591 | +17.9% | 0.00% | – |
Q3 2019 | $72,000 | -11.1% | 1,349 | 0.0% | 0.00% | – |
Q2 2019 | $81,000 | +8.0% | 1,349 | +11.4% | 0.00% | – |
Q1 2019 | $75,000 | +1.4% | 1,211 | 0.0% | 0.00% | – |
Q4 2018 | $74,000 | +57.4% | 1,211 | +50.1% | 0.00% | – |
Q3 2018 | $47,000 | +11.9% | 807 | -14.6% | 0.00% | – |
Q2 2018 | $42,000 | +2.4% | 945 | +2.1% | 0.00% | – |
Q1 2018 | $41,000 | -31.7% | 926 | -33.4% | 0.00% | – |
Q4 2017 | $60,000 | -20.0% | 1,390 | -13.0% | 0.00% | – |
Q3 2017 | $75,000 | -2.6% | 1,597 | +2.5% | 0.00% | – |
Q2 2017 | $77,000 | -8.3% | 1,558 | 0.0% | 0.00% | – |
Q1 2017 | $84,000 | -2.3% | 1,558 | 0.0% | 0.00% | – |
Q4 2016 | $86,000 | +132.4% | 1,558 | +90.9% | 0.00% | – |
Q3 2016 | $37,000 | -57.0% | 816 | -62.7% | 0.00% | – |
Q2 2016 | $86,000 | – | 2,187 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 36,000 | $2,244,000 | 2.71% |
JW Asset Management, LLC | 73,649 | $4,591,000 | 2.36% |
THB ASSET MANAGEMENT | 87,491 | $5,453,000 | 0.79% |
RICE HALL JAMES & ASSOCIATES, LLC | 315,972 | $19,695,000 | 0.63% |
EAM Global Investors LLC | 22,789 | $1,420,000 | 0.63% |
Elk Creek Partners, LLC | 73,936 | $4,608,000 | 0.33% |
Matarin Capital Management, LLC | 69,964 | $4,361,000 | 0.32% |
EAM Investors, LLC | 17,696 | $1,103,000 | 0.27% |
CADENCE CAPITAL MANAGEMENT LLC | 37,196 | $2,318,000 | 0.21% |
Cavalier Investments, LLC | 7,800 | $486,000 | 0.20% |